We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Rambus (RMBS) to Report Q1 Earnings: What's in the Cards?
Read MoreHide Full Article
Rambus, Inc. (RMBS - Free Report) is slated to release first-quarter 2018 results on May 7. Notably, Rambus surpassed the Zacks Consensus Estimate in three of the trailing four quarters, with an average positive surprise of 8.2%.
Let’s take a look at how things are shaping up prior to this announcement.
Factors to Consider
We believe strong adoption of an innovative portfolio will drive Rambus’ top line in the soon-to-be reported quarter.
The company recently announced that it is developing hybrid memory systems in collaboration with International Business Machines (IBM), primarily for use in future data centers.
In January, the company announced the launch of GDDR6 (Graphics Double Data Rate) Memory PHY IP Core aimed at artificial intelligence (AI), ADAS (advanced driver assistance systems), networking and cryptocurrency mining applications.
Rambus is also taking up initiatives to strengthen its position in the Internet of Things (IoT) industry. The company along with Cybertrust Japan Co., Ltd demonstrated Mitsufuji hamon bio-monitoring wearable at the Consumer Electronics Show (CES) in Las Vegas in January. The wearable features Rambus CryptoManager IoT Security Service and the Cybertrust Japan Secur IoT Platform for monitoring security.
At the Mobile World Congress in Barcelona held in February, Rambus demonstrated its CryptoManager IoT security service, mobile payment and smart ticketing solutions. These initiatives are expected to spread awareness about the company’s products thereby driving the company’s financials in the near-term
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or #3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. The Sell-rated stocks (Zacks Rank #4 or #5) are best avoided.
Rambus has a Zacks Rank #3 and an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks to Consider
Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:
Arrow Electronics, Inc. (ARW - Free Report) has an Earnings ESP of +0.66% and a Zacks Rank #2.
Analog Devices, Inc. (ADI - Free Report) has an Earnings ESP of +0.20% and a Zacks Rank #2.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Rambus (RMBS) to Report Q1 Earnings: What's in the Cards?
Rambus, Inc. (RMBS - Free Report) is slated to release first-quarter 2018 results on May 7. Notably, Rambus surpassed the Zacks Consensus Estimate in three of the trailing four quarters, with an average positive surprise of 8.2%.
Let’s take a look at how things are shaping up prior to this announcement.
Factors to Consider
We believe strong adoption of an innovative portfolio will drive Rambus’ top line in the soon-to-be reported quarter.
The company recently announced that it is developing hybrid memory systems in collaboration with International Business Machines (IBM), primarily for use in future data centers.
In January, the company announced the launch of GDDR6 (Graphics Double Data Rate) Memory PHY IP Core aimed at artificial intelligence (AI), ADAS (advanced driver assistance systems), networking and cryptocurrency mining applications.
Rambus is also taking up initiatives to strengthen its position in the Internet of Things (IoT) industry. The company along with Cybertrust Japan Co., Ltd demonstrated Mitsufuji hamon bio-monitoring wearable at the Consumer Electronics Show (CES) in Las Vegas in January. The wearable features Rambus CryptoManager IoT Security Service and the Cybertrust Japan Secur IoT Platform for monitoring security.
At the Mobile World Congress in Barcelona held in February, Rambus demonstrated its CryptoManager IoT security service, mobile payment and smart ticketing solutions. These initiatives are expected to spread awareness about the company’s products thereby driving the company’s financials in the near-term
Rambus, Inc. Price and EPS Surprise
Rambus, Inc. Price and EPS Surprise | Rambus, Inc. Quote
What the Zacks Model Says
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or #3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. The Sell-rated stocks (Zacks Rank #4 or #5) are best avoided.
Rambus has a Zacks Rank #3 and an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks to Consider
Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:
Microchip Technology Incorporated (MCHP - Free Report) has an Earnings ESP of +0.15% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here
Arrow Electronics, Inc. (ARW - Free Report) has an Earnings ESP of +0.66% and a Zacks Rank #2.
Analog Devices, Inc. (ADI - Free Report) has an Earnings ESP of +0.20% and a Zacks Rank #2.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>